Evidence map›Paper›PMID 28789434›Full record

ArticleOncology letters2017

Detection of residual metastatic tumor in the brain following Gamma Knife radiosurgery using a single or a series of magnetic resonance imaging scans: An autopsy study.

Madoka Sakuramachi, Hiroshi Igaki, Masako Ikemura, Hideomi Yamashita, Kae Okuma, Noriyasu Sekiya, Yayoi Hayakawa, Akira Sakumi, Wataru Takahashi, Hirotaka Hasegawa and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Madoka SakuramachiDepartment of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Hiroshi IgakiDepartment of Radiation Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Masako IkemuraDepartment of Pathology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Hideomi YamashitaDepartment of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Kae OkumaDepartment of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Noriyasu SekiyaDepartment of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Yayoi HayakawaDepartment of Radiology, New Tokyo Hospital, Matsudo, Chiba 271-2232, Japan.
Akira SakumiDepartment of Radiation Therapy, NTT Medical Center Tokyo, Tokyo 141-0022, Japan.
Wataru TakahashiDepartment of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Hirotaka HasegawaDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Masashi FukayamaDepartment of Pathology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Keiichi NakagawaDepartment of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
University of Tokyo Hospital · JPNew Tokyo Hospital · JPNTT Medical Center · JPTokyo National Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the usefulness of magnetic resonance image (MRI) for the detection of residual tumors following Gamma Knife radiosurgery (GKR) for brain metastases based on autopsy cases. The study investigated two hypotheses: i) Whether a single MRI may detect the existence of a tumor; and ii) whether a series of MRIs may detect the existence of a tumor. The study is a retrospective case series in a single institution. A total of 11 brain metastases in 6 patients were treated with GKR between 2002 and 2011. Histopathological specimens from autopsy were compared with reconstructed follow-up MRIs. The maximum diameters of the lesions on MRI series were measured, and the size changes classified. The primary sites in the patients were the kidneys (n=2), lung (n=1), breast (n=1) and colon (n=1), as well as 1 adenocarcinoma of unknown origin. The median prescribed dose for radiosurgery was 20 Gy (range, 18-20 Gy), and median time interval between GKR and autopsy was 10 months (range, 1.6-20 months). The pathological outcomes included 7 remissions and 4 failures. Enhanced areas on gadolinium-enhanced MRI contained various components: Viable tumor cells, tumor necrosis, hemorrhage, inflammation and vessels. Regarding the first hypothesis, it was impossible to distinguish pathological failure from remission with a single MRI scan due to the presence of various components. Conversely, in treatment response (remission or failure), on time-volume curves of MRI scans were in agreement with pathological findings, with the exception of progressive disease in the acute phase (0-3 months). Thus, regarding the second hypothesis, time-volume curves were useful for predicting treatment responses. In conclusion, it was difficult to predict treatment response using a single MRI, and a series of MRI scans were required to detect the existence of a tumor.

Indexed as

autopsybrain metastasesfollow-up magnetic resonance imagingGamma Knife radiosurgerypathology

Identifiers

PMID28789434
PMCPMC5530089
OpenAlexW2624235269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.